Renal cell carcinoma treatment
Most cited papers
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine · 2008 · 13,250 citations
- Nivolumab versus Everolimus in Advanced Renal-Cell CarcinomaNew England Journal of Medicine · 2015 · 5,913 citations
- Sunitinib versus Interferon Alfa in Metastatic Renal-Cell CarcinomaNew England Journal of Medicine · 2007 · 5,822 citations
- Acute Abdomen: A Rare Case of Ruptured Hepatocellular CarcinomaCase Reports in Gastroenterology · 2017 · 5,385 citations
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine · 2007 · 4,843 citations
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell CarcinomaNew England Journal of Medicine · 2018 · 4,757 citations
Metadata from OpenAlex (CC0).